Everest Medicines
PublicLast Round
Private Placement
Jul 25, 2025
Est. Valuation
$3.48B
Total Funding Raised
$1.23B
Company Overview
Everest Medicines is a biopharmaceutical company that integrates discovery, licensing, clinical development, commercialization, and manufacturing of innovative therapies and vaccines to address critical unmet medical needs.
Sector
Healthcare
AI Layer
Infrastructure
Keywords
biopharmaceuticalin-licensingIgA nephropathymRNA platformdrug commercializationclinical-stage assetsAI drug discoveryrenal diseaseinfectious diseaseautoimmune disordersbiotechpharma licensingdrug developmentCAR-Tprecision medicinein-vivo CAR-T
Everest Medicines Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Everest Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jul 25, 2025 | ||||
| IPO Announced | Oct 9, 2020 | ||||
| Series C | Jun 4, 2020 | ||||
| Series B | Jun 1, 2019 | ||||
| Series A | Jun 20, 2018 |
Everest Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C, Series B |
| RA Capital Management | IPO, Series C |
| Hillhouse Investment | Series C |
| CBC Group | Private Placement, IPO, Series C, Series B, Series A |
| OrbiMed | IPO |
| GIC Private Limited | IPO |
| HBM Healthcare Investments | Series A, Series C, Series B |
Everest Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersShanghai, Shanghai
Employee Range151
Year Founded2017
Last FundingJul 25, 2025